Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Symptomatic Maintenance Therapy with K-Cab (tegoprazan) in Patients with NERD
KCT0004401Phase 4Completed
- Sponsor
- HK inno.N Corporation
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tegoprazan in gastroesophageal reflux disease (GERD), sponsored by HK inno.N Corporation. Started Jan 2020; status: completed.
02
Drugs
tegoprazan
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on KCT0004401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0004401.